This is a limited company view. Sign up for a Free Trial to see everything.

Actinobac Biomed focuses on the development of pharmaceutical technologies derived from agents that target LFA-1.

B2B
Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

New York

Founded

Employees

0

Stage

Series B

Total funding

$5M

Last funding

7 months ago

Acquisitions

0

Growth score

44

Mindshare score

47

Scoring

Deals

$4.4M Series A

Kairos Ventures

Jul 12, 2017

$100.0K Series B

Foundation Venture Capital Group

Feb 21, 2013

$500.0K Venture

Foundation Venture Capital Group

Mar 20, 2009

Employee Growth

Use Actinobac Biomed's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Actinobac Biomed's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Similar Companies

Merus

battling cancer
Public|68 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes